Metabasis Therapeutics' Series C Round

Metabasis Therapeutics raised a round of funding on October 16, 2003.

Biopharmaceutical company developing products for diabetes, hepatitis, liver cancer, and other liver-related diseases.…

Articles about Metabasis Therapeutics' Series C Round: